Research articles
ScienceAsia 49 (2023):ID 428-436 |doi:
10.2306/scienceasia1513-1874.2023.037
Elevated expression of EAPP is associated with poor prognosis
and promotes tumor progression in epithelial ovarian cancer
Sujuan Yana, Aixiang Yaoa, Hui Tanga, Jiayun Zhaob,*
ABSTRACT: E2F-associated phospho-protein (EAPP) is known to be involved in tumor progression. However, its
molecular mechanisms in epithelial ovarian cancer (EOC) remain unclear. In the present study, we found that EAPP
expression was significantly higher in EOC tissues than in nontumor tissues, and aberrant EAPP expression was
significantly correlated with histological grade (p = 0.019), FIGO stage (p = 0.003), histological subtype (p = 0.019),
lymph node metastasis (p = 0.024), distant metastasis (p = 0.007), and Ki-67 expression (p < 0.001) in EOC. Patients
with high EAPP expression had a significantly lower overall survival rate than those with low EAPP expression. More
importantly, univariate and multivariate analyses suggested that the EAPP expression level and distant metastasis are
independent prognostic risk factors for EOC patients. Furthermore, we demonstrated that EAPP inhibition using siRNA
was associated with decreased cell proliferation and reduced migratory and invasive capability of SK-OV-3 cells, a
human EOC cell line. Together, our study reveals that high expression of EAPP may indicate poor prognosis and play an
essential role in EOC progression. EAPP may, therefore, serve as a potential biomarker and a novel therapeutic target
for EOC patients.
Download PDF
72 Downloads 825 Views
| a |
Department of Obstetrics and Gynecology, The First People?s Hospital of Jingmen, Hubei 448000 China |
| b |
Department of Hepatobiliary Surgery, The First People?s Hospital of Jingmen, Hubei 448000 China |
* Corresponding author, E-mail: 405348081@qq.co
Received 19 Mar 2022, Accepted 19 Dec 2022
|
